Inflammasome-Dependent Coagulation Activation in Sepsis.

Area of Science:

• Immunology
• Pathology
• Molecular Biology

Background:

• Sepsis is a life-threatening condition from a dysregulated host response to infection.
• Systemic inflammation in sepsis can lead to coagulation activation, organ dysfunction, and death.
• Inflammasomes are key regulators of host defense against pathogens and cellular damage.

Purpose of the Study:

• To review the role of inflammasomes in sepsis-induced coagulation.
• To discuss the regulation of inflammasome-dependent immunocoagulation.
• To highlight the involvement of STING1 and HMGB1 in this process.

Main Methods:

• This mini-review synthesizes recent findings on inflammasome activation and its link to coagulation.
• It discusses the molecular mechanisms underlying inflammasome-mediated tissue factor release.
• The review examines the regulatory roles of STING1 and HMGB1 in inflammasome signaling.

Main Results:

• Inflammasome activation releases interleukin-1 (IL-1) family cytokines and tissue factor (TF).
• TF release from macrophages and monocytes promotes coagulation activation in sepsis.
• STING1 and HMGB1 positively regulate inflammasome-dependent coagulation pathways.

Conclusions:

• Inflammasomes play a critical role in linking innate immunity and coagulation during sepsis.
• Understanding inflammasome-driven immunocoagulation offers potential therapeutic targets for sepsis.
• Targeting inflammasome pathways may mitigate sepsis-associated organ dysfunction and mortality.